OpenVSafe by OpenVAERS
Search V-safe

FX7-37058-27453

2 vaccinations 4 coded responses 6 check-ins 4 free-text entries 3 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
118 / NY
Registered
2021-03-11
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-02-06
    Dose 1 — Pfizer-BioNTech
  2. 2021-02-27
    Dose 2 — Pfizer-BioNTech
  3. 2021-03-11
    Registered in v-safe
  4. 2021-03-11
    Survey response — day 7, dose 2
    MedDRA: Back pain, Chest discomfort, Dyspnoea, Glassy eyes, Office visit, Pain — Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Get care from a doctor or other healthcare professional
    Free text: Systemic reaction (other): pressure in chest, pain when transitioning from sitting to laying down, lower back pain, shortness of breath, glossy eye · Healthcare visit (other): I went to my Primary Care Doctor
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-11
    Report sent to call center — day 7, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-03-13
    Survey response — day 14, dose 2
    MedDRA: Chest discomfort, Fatigue, Glassy eyes, Office visit, Pyrexia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Pressure/tightness in chest, tiredness, glossy eyes, lowgrade fever 99.5 · Healthcare visit (other): In person
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-13
    Report sent to call center — day 14, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-03-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-05-29
    Survey response — 3 months, dose 2
    MedDRA: Cardiac disorder, Heart rate increased, Office visit — Feeling: Good
    Free text: High heart rate, saw cardiologist and did echo which found slightly thicker than normal walls of my heart.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-08-28
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-12-17
  12. 2022-02-28
    Survey response — 12 months, dose 2
    MedDRA: Inflammatory marker increased, Optic neuritis, Papilloedema — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: 10 days post booster, optical neuritis/papiladema. Inflammation blood markers were elevated.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2022-02-28
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  14. 2022-03-03
  15. 2022-03-03
    Call successful
    Participant prefers to complete VAERS report online

Vaccinations

DoseDateManufacturerCo-administered
12021-02-06Pfizer-BioNTech
22021-02-27Pfizer-BioNTech

Call center

3 call center cases

3 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 7, dose 2

2021-03-11

Systemic reaction (other): pressure in chest, pain when transitioning from sitting to laying down, lower back pain, shortness of breath, glossy eye
Healthcare visit (other): I went to my Primary Care Doctor

Release 5 — day 14, dose 2

2021-03-13

Symptoms: Pressure/tightness in chest, tiredness, glossy eyes, lowgrade fever 99.5
Healthcare visit (other): In person

Release 8 — 3 months, dose 2

2021-05-29

Symptoms: High heart rate, saw cardiologist and did echo which found slightly thicker than normal walls of my heart.

Release 11 — 12 months, dose 2

2022-02-28

Symptoms: 10 days post booster, optical neuritis/papiladema. Inflammation blood markers were elevated.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDCardiac disorder ✓ ✓ ✓
SDChest discomfort ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDGlassy eyes ✓ ✓ ✓
SDHeart rate increased ✓ ✓ ✓
SDInflammatory marker increased · · ✓
SDOffice visit ✓ ✓ ✓
SDOptic neuritis · · ✓
SDPapilloedema · · ✓
SDPyrexia ✓ ✓ ✓
SROBack pain ✓ ✓ ✓
SROChest discomfort ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROGlassy eyes ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release